Navigation Links
MedCath Corporation to Present at the Raymond James & Associates 30th Annual Institutional Investors Conference
Date:3/3/2009

CHARLOTTE, N.C., March 3 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) announced that its senior management will give a presentation at the Raymond James & Associates 30th Annual Institutional Investors Conference held March 8-11 at the JW Marriott Grande Lakes in Orlando, Florida.

MedCath's senior management will give its presentation on Tuesday, March 10 at 1:40 pm Eastern time. The presentation will be web cast live over the Internet via MedCath's website (www.medcath.com) and will be available for 30 days.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates nine hospitals with a total of 676 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. MedCath is in the process of developing its tenth hospital, which is anticipated to open in fall 2009, in Kingman, Ariz. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.


'/>"/>
SOURCE MedCath Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. MedCath Corporation Reports First Quarter Earnings
2. MedCath Corporation to Hold Conference Call on First Quarter Results
3. MedCath Corporation Announces Completion of Sale of Equity Interest in Joint Venture
4. MedCath Corporation to Hold Conference Call on Fourth Quarter Results
5. MedCath Corporation Reports Third Quarter Earnings
6. MedCath Announces Completion of Sale of Dayton Heart Hospital to Good Samaritan Hospital-Dayton
7. MedCath Names Parker to New Finance Post
8. MedCath Corporation to Present at the Banc of America Securities 2008 Health Care Conference
9. MedCath Corporation Reports Second Quarter Earnings
10. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
11. MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... ... , ... “Sound of My Song”: an intriguing and thought-provoking on love, life, ... a retired teacher with a passion for music and ancestral history. , Published ... on loss, living with depression, and finding love through the journey. There is powerful ...
(Date:9/26/2017)... ... 26, 2017 , ... “The Great Creator Saves Boobie and Ceebie”: a tool families can use ... Ceebie” is the creation of published author, G.S. White, a devoted follower of Jesus Chris ... Jersey. , “This book is not only for children but also to glorified God ...
(Date:9/25/2017)... ... September 25, 2017 , ... The ... the addition of an affiliate in Minneapolis-St. Paul, MN, Dr. Adam Locketz. Dr. ... Naltrexone therapy and aftercare planning through his Timewise Medical practice in the twin ...
(Date:9/25/2017)... ... September 25, 2017 , ... Nissar A. Darmani, PhD, has ... cancer patients suffering from chemotherapy-evoked nausea and vomiting. Dr. Darmani is Associate Dean ... , The five-year grant is from the National Cancer Institute (NCI) arm of ...
(Date:9/25/2017)... ... September 25, 2017 , ... Order Custom Tee Shirts Online ... No need to be concerned about garment selection, expensive graphic designers, substandard printing, ... are printed and shipped within 5-10 days. And every garment we ship ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: